ALPS Advisors’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Sell |
31,274
-10,945
| -26% | -$364K | 0.01% | 491 |
|
|
2025
Q1 | $1.24M | Sell |
42,219
-3,892
| -8% | -$114K | 0.01% | 425 |
|
|
2024
Q4 | $1.52M | Buy |
46,111
+3,105
| +7% | +$102K | 0.01% | 389 |
|
|
2024
Q3 | $1.91M | Sell |
43,006
-1,286
| -3% | -$57.1K | 0.01% | 365 |
|
|
2024
Q2 | $1.91M | Buy |
44,292
+4,652
| +12% | +$201K | 0.01% | 345 |
|
|
2024
Q1 | $1.16M | Buy |
39,640
+1,796
| +5% | +$52.5K | 0.01% | 439 |
|
|
2023
Q4 | $843K | Sell |
37,844
-3,255
| -8% | -$72.5K | 0.01% | 519 |
|
|
2023
Q3 | $1.02M | Buy |
41,099
+243
| +0.6% | +$6.01K | 0.01% | 441 |
|
|
2023
Q2 | $1.16M | Buy |
40,856
+4,434
| +12% | +$126K | 0.01% | 445 |
|
|
2023
Q1 | $837K | Sell |
36,422
-823
| -2% | -$18.9K | 0.01% | 506 |
|
|
2022
Q4 | $1.05M | Buy |
37,245
+7,290
| +24% | +$205K | 0.01% | 471 |
|
|
2022
Q3 | $847K | Sell |
29,955
-2,548
| -8% | -$72K | 0.01% | 500 |
|
|
2022
Q2 | $721K | Sell |
32,503
-23,657
| -42% | -$525K | 0.01% | 525 |
|
|
2022
Q1 | $1.64M | Sell |
56,160
-6,689
| -11% | -$195K | 0.02% | 264 |
|
|
2021
Q4 | $2.07M | Sell |
62,849
-9,405
| -13% | -$309K | 0.02% | 286 |
|
|
2021
Q3 | $3.34M | Sell |
72,254
-8,544
| -11% | -$394K | 0.03% | 202 |
|
|
2021
Q2 | $4.45M | Sell |
80,798
-44,504
| -36% | -$2.45M | 0.04% | 182 |
|
|
2021
Q1 | $6.47M | Buy |
125,302
+385
| +0.3% | +$19.9K | 0.06% | 160 |
|
|
2020
Q4 | $5.41M | Buy |
+124,917
| New | +$5.41M | 0.06% | 172 |
|
|
2019
Q4 | – | Sell |
-117,158
| Closed | -$3.8M | – | 816 |
|
|
2019
Q3 | $3.8M | Sell |
117,158
-5,286
| -4% | -$171K | 0.03% | 166 |
|
|
2019
Q2 | $6.11M | Sell |
122,444
-11,976
| -9% | -$597K | 0.05% | 146 |
|
|
2019
Q1 | $9.07M | Sell |
134,420
-28
| -0% | -$1.89K | 0.06% | 125 |
|
|
2018
Q4 | $6.2M | Buy |
134,448
+31,824
| +31% | +$1.47M | 0.05% | 137 |
|
|
2018
Q3 | $7.91M | Buy |
102,624
+19,327
| +23% | +$1.49M | 0.05% | 130 |
|
|
2018
Q2 | $7.02M | Buy |
83,297
+8,580
| +11% | +$723K | 0.05% | 139 |
|
|
2018
Q1 | $6.11M | Buy |
74,717
+21,301
| +40% | +$1.74M | 0.05% | 131 |
|
|
2017
Q4 | $3.05M | Buy |
53,416
+5,943
| +13% | +$340K | 0.02% | 166 |
|
|
2017
Q3 | $3.17M | Buy |
47,473
+3,962
| +9% | +$264K | 0.02% | 160 |
|
|
2017
Q2 | $2.24M | Buy |
43,511
+7,176
| +20% | +$369K | 0.02% | 178 |
|
|
2017
Q1 | $2.12M | Sell |
36,335
-4,042
| -10% | -$236K | 0.01% | 173 |
|
|
2016
Q4 | $1.69M | Sell |
40,377
-8,125
| -17% | -$339K | 0.01% | 186 |
|
|
2016
Q3 | $2.56M | Sell |
48,502
-4,770
| -9% | -$252K | 0.02% | 171 |
|
|
2016
Q2 | $2.23M | Buy |
53,272
+10,941
| +26% | +$458K | 0.02% | 163 |
|
|
2016
Q1 | $1.72M | Sell |
42,331
-7,255
| -15% | -$295K | 0.02% | 161 |
|
|
2015
Q4 | $3.22M | Buy |
+49,586
| New | +$3.22M | 0.03% | 147 |
|